Krsnaa Diagnostics Limited — Q2FY27 earnings call summary

Filed 07 November 2026 · Official transcript

EBITDA margin at 27% in Q2, slight moderation due to Rajasthan project ramp-up
H1 FY27 revenue crossed INR 507 Cr, +27% y-y; Q2 revenue INR 271 Cr, +32% y-y
Rajasthan project ramp-up ongoing; expected INR 250 Cr annualized revenue next year
Receivables at INR 470 Cr; INR 200 Cr expected collection in Q3
Cash-based revenues targeted at 40-45% of total by FY27, improving cash flow
New PPP projects in PET-CT and CT scans to drive growth
Retail business operational breakeven expected by Q3-Q4 FY27
Retail revenue INR 23.5 Cr in Q2, +35% y-y; retail to reach double-digit % of revenue in 2-3 years